Trials / Conditions / PR-Negative Breast Cancer
PR-Negative Breast Cancer
3 registered clinical trials studyying PR-Negative Breast Cancer — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo NCT04675827 | Jules Bordet Institute | Phase 2 |
| Terminated | A Study of Zilovertamab Vedotin (MK-2140/VLS-101) in Participants With Solid Tumors (MK-2140-002) NCT04504916 | VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Recruiting | Sacituzumab Govitecan In TNBC NCT04230109 | Massachusetts General Hospital | Phase 2 |